290
Biophysical Society 58
th
Annual Meeting, San Francisco, California
Authors of submitted abstracts completed a disclosure statement. Disclosures included any relationships that may bias one’s
presentation or which, if known, could give the perception of bias. These situations include but are not limited to:
1. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
2. Research funded by industry grant
3. Employment (full- or part-time) in funding company
4. Ownership or Partnership in funding organization
5. Consulting fees or other remuneration from industry
6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson in company
7. Receipt of royalties from referenced company products
8. Speaker’s bureau
9. Other
Below is the list of authors and disclosures for programmed abstracts.
Author Disclosures
Name
Disclosure Entity
Disclosure Type
Presentation Number
Abdeladim, Lamiae
Phasics
Employment (full or part-time) in funding company 2904-Pos
Ackerman, Michael J.
Other/Royalties (significant or >
10 K but < 50K/year category) –
Transgenomic
Other
2798-Pos
Ainla, Alar
Co-founder of Avalance Biotech AB Stock options or bond holdings in a for-profit
corporation or self-directed pension plan
1055-Pos
Akeson, Mark
Oxford Nanopore Technologies
Consulting fees or other remuneration from industry 1083-Pos
Aknoun, Sherazade
Phasics
Employment (full or part-time) in funding company 2904-Pos
Aknoun, Sherazade
PHASICS S.A.
Employment (full or part-time) in funding company 3041-Pos
Aknoun, Sherazade
PHASICS S.A.
Employment (full or part-time) in funding company 3045-Pos
Alexander, Leila T.
Structural Genomics Consortium Research funded by industry grant
108-Plat
Alkhamici, Heba
SDx Tethered Membranes Pty Ltd Employment (full or part-time) in funding company 1500-Pos
Alvarenga, Érika C.
INCT
Other
1554-Pos
Amodaj, Nenad
Aratome LLC
Ownership or Partnership in funding organization 2012-Pos
Anderson, Robert L.
MyoKardia Inc
Stock options or bond holdings in a for-profit
corporation or self-directed pension plan
3692-Pos
Appleby, Todd
Gilead Sciences Inc.
Stock options or bond holdings in a for-profit
corporation or self-directed pension plan
1330-Pos
Aussenac, Fabien
Bruker
Employment (full or part-time) in funding company 2228-Plat
Bammes, Benjamin
Driect Electron
Employment (full or part-time) in funding company 3031-Pos
Barauskas, Ona
Gilead Sciences Inc.
Stock options or bond holdings in a for-profit
corporation or self-directed pension plan
1330-Pos
Barker, Oliver
Evotec (UK) Ltd
Employment (full or part-time) in funding company 90-Plat
Bayley, Hagan
Oxford Nanopore Technologies
Stock options or bond holdings in a for-profit
corporation or self-directed pension plan
108-Plat
Bechinger, Burkhard
Bruker - CNRS PhD grant to
H. Sarrouj
Research funded by industry grant
2228-Plat
